Research

Once a COVID-19 vaccine is developed, achieving universal immunization will require a cohesive, multi-faceted vaccination strategy across the U.S. healthcare system.

To reopen safely, employers need to identify workers who have active COVID-19 infections and do so at reasonable cost. Pooled testing for the coronavirus is an effective, scalable tool for doing so.

Instead of just short-term substitution from prescription opioid to heroin overdoses, the transition to illicit markets spurred by reformulation led to growth in the overall overdose rate to unprecedented levels.

This simulation study used real-world data to compare model performance across a range of important statistical constructs to better understand which methods are appropriate for measuring the impacts of state-level opioid policies on opioid-related mortality.

One-in-twelve episodes at ambulatory surgery centers had the potential to result in a surprise medical bill, according to the study.

Auto-enrollment into health insurance coverage is an attractive policy that can drive the U.S. health care system towards universal coverage.

The speed and extent of biosimilar penetration differ across provider types. Provider awareness and incentives are significantly associated with biosimilar uptake.

If cost-sharing were based on net price it would provide meaningful financial relief to many Part D beneficiaries.

Drugs already being used to treat high blood pressure and cholesterol could reduce the risk of Alzheimer’s disease and dementia, according to a new Schaeffer Center study of nearly 700,000 Medicare beneficiaries.

The researchers find a 10% increase in opioid medical supply leads to a 7.1% increase in opioid-related deaths among the Medicare-ineligible population.